(Q42473382)

1 November 2017

title

Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights (English)

1 reference

1 November 2017

0 references

François-Clément Bidard

series ordinal

3

object named as

Francois-Clement Bidard

0 references

Jorge Reis-Filho

series ordinal

5

object named as

Jorge S Reis-Filho

1 reference

1 November 2017

4

Britta Weigelt

1 reference

1 November 2017

2

Anne M Schultheis

1 reference

1 November 2017

Charlotte K Y Ng

1

1 reference

1 November 2017

language of work or name

English

0 references

publication date

23 February 2015

1 reference

Journal of the National Cancer Institute

1 November 2017

published in

1 reference

1 November 2017

volume

107

1 reference

1 November 2017

issue

5

1 reference

Gene expression profiling in breast cancer: classification, prognostication, and prediction

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Outcome of special types of luminal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Tubular carcinoma of the breast: further evidence to support its excellent prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Sequence analysis of mutations and translocations across breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Breast cancer prognostic classification in the molecular era: the role of histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A refined molecular taxonomy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A new genome-driven integrated classification of breast cancer and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Novel patterns of genome rearrangement and their association with survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A three-gene model to robustly identify breast cancer molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A clinically relevant gene signature in triple negative and basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Mutational landscape and significance across 12 major cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Discovery and saturation analysis of cancer genes across 21 tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Diverse somatic mutation patterns and pathway alterations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

MuSiC: identifying mutational significance in cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Mutational heterogeneity in cancer and the search for new cancer-associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Identifying cancer driver genes in tumor genome sequencing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Activating HER2 mutations in HER2 gene amplification negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Metaplastic breast carcinoma: more than a special type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

The life history of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Clonal evolution in breast cancer revealed by single nucleus genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Exploring the genomes of cancer cells: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Epistatic interactions and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genetic and phenotypic diversity in breast tumor metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Emerging landscape of oncogenic signatures across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

APOBEC3B is an enzymatic source of mutation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Evidence for APOBEC3B mutagenesis in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Mutational processes molding the genomes of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Pan-cancer patterns of somatic copy number alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Criteria for inference of chromothripsis in cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Punctuated evolution of prostate cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Inferring tumor progression from genomic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genetic clonal diversity predicts progression to esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Circulating tumor cells: liquid biopsy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Circulating tumor cells: approaches to isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Going with the flow: from circulating tumor cells to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Detection of circulating tumor DNA in early- and late-stage human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Predicting the functional impact of protein mutations: application to cancer genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

A general framework for estimating the relative pathogenicity of human genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Predicting the functional consequences of cancer-associated amino acid substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

An integrated encyclopedia of DNA elements in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

Selection and adaptation during metastatic cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV015

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJV015

1 reference

1 November 2017

1 reference